See-Ying Tam

(1) Our current effort is focused on the elaboration of our recently developed technology platform that employs functional genomics coupled with high-resolution single-cell confocal microscopy for rapid identification of regulators of degranulation in human mast cells, by implementing new CRISPR technologies. (2) We are currently engaging in the characterization of combinatorial phenotypic and genomic biomarkers of human mast cells derived from normal donors and patients with allergic diseases.